These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1839 related articles for article (PubMed ID: 9072974)
1. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Li J; Yen C; Liaw D; Podsypanina K; Bose S; Wang SI; Puc J; Miliaresis C; Rodgers L; McCombie R; Bigner SH; Giovanella BC; Ittmann M; Tycko B; Hibshoosh H; Wigler MH; Parsons R Science; 1997 Mar; 275(5308):1943-7. PubMed ID: 9072974 [TBL] [Abstract][Full Text] [Related]
2. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738 [TBL] [Abstract][Full Text] [Related]
3. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Li DM; Sun H Cancer Res; 1997 Jun; 57(11):2124-9. PubMed ID: 9187108 [TBL] [Abstract][Full Text] [Related]
4. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672 [TBL] [Abstract][Full Text] [Related]
5. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Steck PA; Pershouse MA; Jasser SA; Yung WK; Lin H; Ligon AH; Langford LA; Baumgard ML; Hattier T; Davis T; Frye C; Hu R; Swedlund B; Teng DH; Tavtigian SV Nat Genet; 1997 Apr; 15(4):356-62. PubMed ID: 9090379 [TBL] [Abstract][Full Text] [Related]
6. New tumor suppressor found--twice. Pennisi E Science; 1997 Mar; 275(5308):1876-8. PubMed ID: 9122687 [No Abstract] [Full Text] [Related]
7. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Vlietstra RJ; van Alewijk DC; Hermans KG; van Steenbrugge GJ; Trapman J Cancer Res; 1998 Jul; 58(13):2720-3. PubMed ID: 9661880 [TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766 [TBL] [Abstract][Full Text] [Related]
9. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052 [TBL] [Abstract][Full Text] [Related]
10. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Liu W; James CD; Frederick L; Alderete BE; Jenkins RB Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744 [TBL] [Abstract][Full Text] [Related]
11. PTEN gene and integrin signaling in cancer. Tamura M; Gu J; Tran H; Yamada KM J Natl Cancer Inst; 1999 Nov; 91(21):1820-8. PubMed ID: 10547389 [TBL] [Abstract][Full Text] [Related]
12. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Wang SI; Parsons R; Ittmann M Clin Cancer Res; 1998 Mar; 4(3):811-5. PubMed ID: 9533551 [TBL] [Abstract][Full Text] [Related]
13. Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts. Schmidt EE; Ichimura K; Goike HM; Moshref A; Liu L; Collins VP J Neuropathol Exp Neurol; 1999 Nov; 58(11):1170-83. PubMed ID: 10560660 [TBL] [Abstract][Full Text] [Related]
14. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines. Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Whang YE; Wu X; Suzuki H; Reiter RE; Tran C; Vessella RL; Said JW; Isaacs WB; Sawyers CL Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5246-50. PubMed ID: 9560261 [TBL] [Abstract][Full Text] [Related]
17. Analysis of PTEN and the 10q23 region in primary prostate carcinomas. Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022 [TBL] [Abstract][Full Text] [Related]
18. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Tashiro H; Blazes MS; Wu R; Cho KR; Bose S; Wang SI; Li J; Parsons R; Ellenson LH Cancer Res; 1997 Sep; 57(18):3935-40. PubMed ID: 9307275 [TBL] [Abstract][Full Text] [Related]
19. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the PTEN gene in human meningiomas. Peters N; Wellenreuther R; Rollbrocker B; Hayashi Y; Meyer-Puttlitz B; Duerr EM; Lenartz D; Marsh DJ; Schramm J; Wiestler OD; Parsons R; Eng C; von Deimling A Neuropathol Appl Neurobiol; 1998 Feb; 24(1):3-8. PubMed ID: 9549723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]